Effect of paclitaxel (Taxol®) on the biodistribution of sodium pertechnetate (Na99mTcO4) in female Wistar rats

Brazilian Archives of Biology and Technology

Volumn 51, Issue SPECIALISSUE, 2008, Pages 191-196

  de Carvalho Xavier Holanda, Cecília Maria ^a   de Oliveira, Elias Herculano ^a   da Rocha, Louisianny Guerra ^a   de Arruda Barbosa, Vanessa Santos ^a   Spyrides, Maria Helena Constantino ^a   Aragão, Cícero Flávio Soares ^a   da Cunha Medeiros, Aldo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Antitumoral drug; Cancer; Drug interaction; Paclitaxel; Radiopharmaceuticals

Indexed keywords

EID: 70349905788     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132008000700031     Document Type: Article

References (28)

1. Akerley, W. (2000), Paclitaxel in advanced non-small cell lung cancer: an alternative to high-dose weekly schedule. Chest., 117, 152-155.
2. 99mTc) in Wistar rats. Cell Mol Biol., 49, 501-507.
3. Ang-Lee, M. K.; Moss, J.; Yuan, C. S. (2001), Herbal medicines and perioperative care. J Am Med Assoc., 286, 208-216.
4. Bernardo-Filho, M.; Santos-Filho, S. D.; Moura, E. G.; Maiworm, A. I.; Orlando, M. M. C.; Penas, M. E.; Cardoso, V. N.; Bernardo, L. C.; Brito, L. C. (2005), Drug interaction with radiopharmaceuticals: a review. Braz Arch Biol Technol., 48, 13-27.
5. Boutet, I.; Meistertzheim, A.; Tanguy, A.; Thébault, M.; Moraga, D. (2005), Molecular characterization and expression of the gene encoding aspartate aminotransferase from the Pacific oyster Crassostrea gigas exposed to environmental stressors. Comp Biochem Physiol C., 140, 69-78.
6. Briskin, D. P. (2000), Medicinal plants and phytomedicines. Plant Physiol., 124, 507-514.
7. Chan, K. (2003), Some aspects of toxic contaminants in herbal medicine. Chemosphere., 52, 1361-1371.
8. Choi, J. S.; Li, X. (2005), The effect of verapamil on the pharmacokinetics of paclitaxel in rats. Eur J Pharm Sci., 24, 95-100.
9. Beshbishy E. (2005), The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol., 38, 300-306.
10. Feldweg, A. M.; Lee, C. W.; Matulonis, U. A.; Castells, M. (2005), Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol., 96, 824-829.
11. Hanahan, D.; Weinberg, R. A. (2000), The hallmarks of cancer. Cell, 100, 57-70.
12. Holanda, C. M. C. X.; Holanda-Leite, R. C.; Nunes, R. A. S. N.; Oliveira, H. A.; Catanho, M. T. J. A.; Souza, G. M. L.; Bernardo-Filho, M. (2006), Effect of antimalarial drugs on the bioavailability of the methylenediphosphonic acid labeled with technetium99m (99mTc-MDP) in Wistar rats. Braz Arch Biol Technol., 49, 207-214.
13. Itoh, Y.; Sendo, T.; Hirakawa, T.; Goromaru, T.; Takasaki, S.; Yahata, H. et al. (2004), Sensory nerve peptides rather than mast cell histamine are involved in paclitaxel hypersensitivity reactions. Am J Resp Crit Care Med., 169, 111-119.
14. Lahowel, M.; Fillastre, J. P. (2004), Role of flavonoids in the prevention of haematoxicity due to chemotherapeutic agents. Haema., 7, 313-320.
15. Mankoff, D. A.; Shields, A. F.; Krohn, K. A. (2005), PET imaging of cellular proliferation. Radiol Clin N Am., 43, 153-167.
16. Nutt, R. (2002), The history of positron emission tomography (PET). Mol Imag Biol., 4, 11-26.
17. Rajendran, J. G.; Mankoff, D. A. (2007), Beyond detection: novel applications for PET imaging to guide cancer therapy. J Nucl Med., 48, 855-856.
18. Rosenblum, M. D.; Shivers, R. R. (2000), Rings' of Factin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. Comp Biochem Physiol C., 125, 121-131.
19. Saha, G. B. (2004), Fundamentals of Nuclear Pharmacy, Springer-Verlag, New York.
20. Santos-Filho, S. D.; Bernardo-Filho, M. (2005), Efeito de um extrato de Hipérico (Hypericum perforatum) na marcação in vitro de elementos sangüíneos com tecnécio-99m e na biodisponibilidade do radiofármaco pertecnetato de sódio em ratos Wistar. Acta Cir Bras., 20, 76-80.
21. Schlyer, D. J. (2003), Production of radionuclides in accelerators. In-Handbook of Radiopharmaceuticals, Radiochemistry and Applications, eds. Welch, M. J., Redvanley, C. S. John Wiley and Sons, New York, pp. 10-15.
22. Souza, M. V. N. (2004), Novos produtos naturais capazes de atuar na estabilização de microtúbulos: um importante alvo no combate ao câncer. Quím Nova., 27(2), 1-16.
23. Sparreboom, A.; van Asperen, J.; Mayer, U.; Schinkel, A. H.; Smit, J. W.; Meijer, D. K. et al. (1997), Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by Pglycoprotein in the intestine. Proc Natl Acad Sci., 4, 2031-2035.
24. Steinkellner, H.; Rabot, S.; Freywald, C.; Nobis, E.; Scharf, G.; Chabicovsky, M. et al. (2001) Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res., 48, 285-297.
25. Thrall, J. H.; Ziessman, H. A. (2003), Medicina Nuclear, Guanabara Koogan, Rio de Janeiro.
26. Vallabhajosula, S., (2007), 18F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Sem Nucl Med., 400-419.
27. Vaclavikova, R.; Horsky, S.; Simerk, P.; Gut, I. (2003), Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants. Arch Pharmacol., 368, 200-209.
28. Xavier-Holanda, C. M. C.; Cavalcanti-Jales, R. L.; Almeida-Catanho, M. T.; Holanda-Leite, R.C.; Lopes de Britto, L. M.; Jales-Jr., L. H.; Brandão, K.C.; Amorim, L. F, de Brito Tiago, G. G.; Gomes, M.L.; Bernardo-Filho, M. (2002), Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. Cell Mol Biol., 48, 761-765.